EC Healthcare (2138) Stock Statistics & Valuation Metrics

EC Healthcare has a market cap or net worth of HK$746.68M. The enterprise value is HK$1.44B.

EC Healthcare has 1,185,211,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

EC Healthcare’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 3.90%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, EC Healthcare had revenue of 4.21B and earned -18.95M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 793.32M and capital expenditures -161.22M, giving a free cash flow of 632.09M billion.

EC Healthcare pays an annual dividend of HK$0.01, resulting in a dividend yield of 1.59%

EC Healthcare upcoming earnings date is Nov 27, 2025, TBA (Confirmed).

EC Healthcare as a current ratio of 0.92, with Debt / Equity ratio of 74.89%

In the past 12 months, EC Healthcare has paid 1.18M in taxes.

EC Healthcare EV to EBITDA ratio is 3.51, with an EV/FCF ratio of 4.91.

EC Healthcare has HK$866.42M in cash and marketable securities with HK$1.51B in debt, giving a net cash position of HK$639.98M billion.

Gross margin is 32.38%, with operating margin of 4.42%, and net profit margin of -0.45%.

The average price target for EC Healthcare is HK$4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy